Jane Street Group, LLC Addex Therapeutics Ltd. Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.34 - $0.62 $3,596 - $6,558
10,578 New
10,578 $4,000
Q1 2023

May 15, 2023
BUY
$0.68 - $2.19 $7,926 - $25,528
11,657 New
11,657 $11,000

About Addex Therapeutics Ltd.

ADXN Quotes by TradingView
  • Ticker ADXN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,204,630
  • Market Cap $68.1M
  • Description
  • Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...
More about ADXN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email